a clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), along ...

Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.

With the NCI funding—which follows Piece's $25 million growth financing round announced in September—Pieces will partner with ...

QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year ...

LaShae Rolle shares her journey of being diagnosed with a rare breast cancer at the age of 26, making her a part of the less ...

The NIH’s current system for funding scientific research perpetuates health disparities by privileging established, well-resourced institutions and reinforcing an individual-level focus on disease ...

The Texas Attorney General's office announced a settlement with the tech company in a release that Pieces called a "damaging ...

Pentixapharm itself is currently preparing a US-centric Phase III pivotal study to obtain marketing authorization for PentixaFor in PA. The work of the NCI/NIDDK will add to the global clinical ...

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years after treatment ends.

BUFFALO, N.Y. — The University at Buffalo School of Dental Medicine has received a $7.38 million grant from the Office of ...